Abstract:Introduction: Cell proliferation represents a major hallmark of cancer biology, and manifests itself in the assessment of tumor growth, drug resistance and metastasis. Tracking cell proliferation or cell fate at the single-cell level can reveal phenotypic heterogeneity. However, characterization of cell proliferation is typically done in bulk assays which does not inform on cells that can proliferate under given environmental perturbations. Thus, there is a need for single-cell approaches that allow longitudinal tracking of the fate of a large number of individual cells to reveal diverse phenotypes. Methods: We fabricated a new microfluidic architecture for high efficiency capture of single tumor cells, with the capacity to monitor cell divisions across multiple daughter cells. This single-cell proliferation (SCP) device enabled the quantification of the fate of more than 1000 individual cancer cells longitudinally, allowing comprehensive profiling of the phenotypic heterogeneity that would be otherwise masked in standard cell proliferation assays. We characterized the efficiency of single cell capture and demonstrated the utility of the SCP device by exposing MCF-7 breast tumor cells to different doses of the chemotherapeutic agent doxorubicin. Results: The single cell trapping efficiency of the SCP device was found to be ~ 85%. At the low doses of doxorubicin (0.01 µM, 0.001 µM, 0.0001 µM), we observed that 50-80% of the drug-treated cells had undergone proliferation, and less than 10% of the cells do not proliferate. Additionally, we demonstrated the potential of the SCP device in circulating tumor cell applications where minimizing target cell loss is critical. We showed selective capture of breast tumor cells from a binary mixture of cells (tumor cells and white blood cells) that was isolated from blood processing. We successfully characterized the proliferation statistics of these captured cells despite their extremely low counts in the original binary suspension. Conclusions: The SCP device has significant potential for cancer research with the ability to quantify proliferation statistics of individual tumor cells, opening new avenues of investigation ranging from evaluating drug resistance of anti-cancer compounds to monitoring the replicative potential of patient-derived cells. Supplementary information: The online version contains supplementary material available at 10.1007/s12195-023-00773-z.

Microfluidics-Based Single-Cell Protrusion Analysis for Screening Drugs Targeting Subcellular Mitochondrial Trafficking in Cancer Progression.

Screening and Identification of Small Molecule Compounds Perturbing Mitosis Using Time-Dependent Cellular Response Profiles.

Spatially Resolved Single-Molecule Profiling of Micrornas in Migrating Cells Driven by Microconfinement

High Throughput Confined Migration Microfluidic Device for Drug Screening (Small 16/2023)

Construction of single-cell arrays and assay of cell drug resistance in an integrated microfluidic platform

High-Throughput, Time-Resolved Mechanical Phenotyping of Prostate Cancer Cells

AI-aided high-throughput profiling of single-cell migration and proliferation on addressable dual-nested microwell arrays

Utilizing a High-Throughput Microfluidic Platform to Study Hypoxia-Driven Mesenchymal-Mode Cell Migration

Drug cytotoxicity and signaling pathway analysis with three-dimensional tumor spheroids in a microwell-based microfluidic chip for drug screening.

Microfluidic Co-Culture System for Cancer Migratory Analysis and Anti-Metastatic Drugs Screening.

Microfluidic Analysis for Separating and Measuring the Deformability of Cancer Cell Subpopulations

Microfluidic Systems for Studying Cell Migration Regulation

Single-Cell Proliferation Microfluidic Device for High Throughput Investigation of Replicative Potential and Drug Resistance of Cancer Cells

Microfluidic Cytometric Analysis of Cancer Cell Transportability and Invasiveness

Single Living Cell Analysis Nanoplatform for High-Throughput Interrogation of Gene Mutation and Cellular Behavior

Integrated Microfluidic Platform with Multiple Functions To Probe Tumor-Endothelial Cell Interaction.

A Microfluidic Digital Single-Cell Assay for the Evaluation of Anticancer Drugs.

Mesenchymal-mode Migration Assay and Antimetastatic Drug Screening with High-Throughput Microfluidic Channel Networks.

Development of Microfluidic Platform Capable of High-Throughput Absolute Quantification of Single-Cell Multiple Intracellular Proteins from Tumor Cell Lines and Patient Tumor Samples.

Discovery of Metastatic Regulators using a Rapid and Quantitative Intravital Chick Chorioallantoic Membrane Model